Zhejiang Yatai Pharmaceutical announcement, the company recently received the acceptance notice for the consistency evaluation of Atorvastatin tablets issued by the National Medical Products Administration. Atorvastatin tablets are mainly used for the treatment of hypertension, angina pectoris, myocardial infarction, as well as arrhythmia, hyperthyroidism, and pheochromocytoma.
亚太药业：收到阿替洛尔片一致性评价受理通知书
Zhejiang Yatai Pharmaceutical: Received the acceptance notice for the consistency evaluation of Atorvastatin tablets.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated